Advertisement

Internal and Emergency Medicine

, Volume 5, Issue 2, pp 103–109 | Cite as

Upper extremity deep vein thrombosis

  • Luca Spiezia
  • Paolo SimioniEmail author
IM - Review

Abstract

Upper extremities deep venous thrombosis (UEDVT) is a rare condition. According to the literature, approximately 4–10% of all cases of venous thrombosis may involve the subclavian, axillary or brachial veins. In the last few decades, the incidence of UEDVT has increased because of more frequent use of central venous catheters (CVCs) and cardiac pacemaker implantation. In addition, another common risk factor for UEDVT is cancer. UEDVT is classified as primary, approximately one-third of cases, which refers either to effort thrombosis or idiopathic UEDVT, or secondary, due to the presence of overt predisposing causes. The onset of UEDVT is usually characterized by arm swelling and pain, but may also be completely asymptomatic especially in patients with a long-term presence of a CVC. Ultrasonography represents a simple and accurate diagnostic tool to demonstrate the problem. UEDVT has major clinical consequences including pulmonary embolism, recurrences, post-thrombotic syndrome, and death. The role of thromboprophylaxis for those patients with a long-term CVC is still controversial. Unfractionated or low molecular weight heparin, followed by an oral anticoagulant are the most common treatments, with strategy of management similar to that of deep vein thrombosis of the leg. Thrombolysis/thrombectomy and surgical decompression are often successful, but less frequently used. Randomized controlled trials are warranted to clarify the optimal management of UEDVT, and to identify patients at the highest risk of recurrence who might benefit from long-term anticoagulation.

Keywords

Upper extremity deep vein thrombosis Central venous catheters Risk factors Prophylaxis and treatment of UEDVT 

Notes

Conflict of interest statement

The authors declare that they have no conflict of interest related to the publication of this manuscript.

References

  1. 1.
    Joffe HV, Kucher N, Tapson VF, Goldhaber SZ (2004) Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 110:1605–1611CrossRefPubMedGoogle Scholar
  2. 2.
    Bernardi E, Pesavento R, Prandoni P (2006) Upper extremity deep venous thrombosis. Semin Thromb Hemost 32:729–736CrossRefPubMedGoogle Scholar
  3. 3.
    Spencer FA, Emery C, Lessard D, Goldberg RJ, for the Worcester Venous Thromboembolism Study (2007) Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 120:678–684CrossRefPubMedGoogle Scholar
  4. 4.
    Hill SL, Berry RE (1990) Subclavian vein thrombosis: a continuing challenge. Surgery 108:1–9PubMedGoogle Scholar
  5. 5.
    De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 86:101–113CrossRefPubMedGoogle Scholar
  6. 6.
    Lindbland B, Tengborn L, Bergqvist D (1988) Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg 2:161–165CrossRefGoogle Scholar
  7. 7.
    Sanders RJ, Hammond SL, Rao NM (2008) Thoracic outlet syndrome. Neurologist 14:365–373CrossRefPubMedGoogle Scholar
  8. 8.
    Von-Schroetter LF (1884) Erkrandungen der Gefaesse. In: Nothnagel H (ed) Spezielle Pathologie und Therapie. Nathnogel Handbuch der Pathologie und Therapie. Holder, ViennaGoogle Scholar
  9. 9.
    Paget J (1875) Clinical lectures and essays. Longmans Green, LondonGoogle Scholar
  10. 10.
    Jamieson CW (1987) Venous complications of the thoracic outlet syndrome. Eur J Vasc Surg 1:1–3CrossRefPubMedGoogle Scholar
  11. 11.
    Van Stralen KJ, Blom JW, Doggen CJM, Rosendaal FR (2005) Strenuous sport activities involving the upper extremities increase the risk of venous thrombosis of the arm. J Thromb Haemost 3:2110–2111CrossRefPubMedGoogle Scholar
  12. 12.
    Girolami A, Prandoni P, Zanon E, Bagattella P, Girolami B (1999) Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. Blood Coagul Fibrinolysis 10:455–457CrossRefPubMedGoogle Scholar
  13. 13.
    Blom JW, Doggen CJM, Osanto S, Rosendaal FR (2005) Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost 3:2471–2478CrossRefPubMedGoogle Scholar
  14. 14.
    Bedarida GV, Hoffmann U, Tatò F (2006) Jugular vein thrombosis with severe local and systemic inflammation in a woman with ovarian hyperstimulation syndrome. Thromb Haemost 95:1035–1037PubMedGoogle Scholar
  15. 15.
    Munoz FJ, Mismetti P, Poggio R, for the RIETE investigators et al (2008) Clinical outcome of patients with upper-extremity deep vein thrombosis. Results from the RIETE registry. Chest 133:143–148CrossRefPubMedGoogle Scholar
  16. 16.
    Lee AY, Levine MN, Butler G, Webb C, Costantini L, Gu C, Julian JA (2006) Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24:1404–1408CrossRefPubMedGoogle Scholar
  17. 17.
    Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM (2004) Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 110:566–570CrossRefPubMedGoogle Scholar
  18. 18.
    Grove JR, Pevec WC (2000) Venous thrombosis related to the peripherally inserted central catheters. J Vasc Interv Radiol 11:837–840CrossRefPubMedGoogle Scholar
  19. 19.
    Prandoni P, Polistena P, Bernardi E, Cogo A et al (1997) Upper-extremity deep vein thrombosis. Arch Intern Med 157:57–62CrossRefPubMedGoogle Scholar
  20. 20.
    Héron E, Lozinguez O, Alhenc-Gelas M, Emmerich J, Fiessinger JN (2000) Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med 160:382–386CrossRefPubMedGoogle Scholar
  21. 21.
    Leebeek FW, Stadhouders NA, van Stein D, Gómez-García EB, Kappers-Klunne MC (2001) Hypercoagulability states in upper-extremity deep venous thrombosis. Am J Hematol 67:15–19CrossRefPubMedGoogle Scholar
  22. 22.
    Ruggeri M, Castaman G, Tosetto A, Rodighiero F (1997) Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs. Blood Coagul Fibrinolysis 8:191–194CrossRefPubMedGoogle Scholar
  23. 23.
    Bombeli T, Basic A, Fehr J (2002) Prevalence of hereditary thrombophilia in patients with thrombosis in different venous system. Am J Hematol 70:126–132CrossRefPubMedGoogle Scholar
  24. 24.
    Linnemann B, Meister F, Schwonberg J, Schindewolf M, Zgouras D, Lindhoff-Last E (2008) Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost 100:440–446PubMedGoogle Scholar
  25. 25.
    Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, van der Meer FJ, Huisman MV (2004) The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 89:201–206PubMedGoogle Scholar
  26. 26.
    Sanders RJ, Haug CE (1991) Thoracic outlet syndrome: a common sequela of neck injuries. In: Lippincott WW (ed) Thoracic outlet syndrome. Lippincott, PhiladelphiaGoogle Scholar
  27. 27.
    Mustafa BO, Rathbun SW, Whitsett TL, Raskob GE (2002) Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch Intern Med 162:401–404CrossRefPubMedGoogle Scholar
  28. 28.
    Fraser JD, Anderson DR (1999) Deep venous thrombosis: recent advances and optimal investigation with US. Radiology 211:9–24PubMedGoogle Scholar
  29. 29.
    Haire WD, Lynch TG, Lund GB, Lieberman RP, Edney JA (1991) Limitations of magnetic resonance imaging and ultrasound-directed (duplex) scanning in the diagnosis of subclavian vein thrombosis. J Vasc Surg 13:391–397CrossRefPubMedGoogle Scholar
  30. 30.
    Constans J, Salmi LR, Sevestre-Pietri MA et al (2008) A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 99:202–207PubMedGoogle Scholar
  31. 31.
    Baarslag HJ, van Beek EJ, Koopman MMW, Reekers JA (2002) Prospective study of colour Duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 135:865–872Google Scholar
  32. 32.
    Lensing AW, Buller HR, Prandoni P, Batchelor D, Molenaar AH, Cogo A, Vigo M, Huisman PM, ten Cate JW (1992) Contrast venography, the gold standard for the diagnosis: improvement in observer agreement. Thromb Haemost 67:8–12PubMedGoogle Scholar
  33. 33.
    Hartnell GG, Hughes LA, Finn JP, Longmaid HE 3rd (1995) Magnetic resonance angiography of the central chest veins. A new gold standard? Chest 107:1053–1057CrossRefPubMedGoogle Scholar
  34. 34.
    Joffe HV, Goldhaber SZ (2002) Upper-extremity deep vein thrombosis. Circulation 106:1874–1880CrossRefPubMedGoogle Scholar
  35. 35.
    Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:454S–545SCrossRefPubMedGoogle Scholar
  36. 36.
    Sabeti S, Schillinger M, Mlekusch W, Haumer M, Ahmadi R, Minar E (2002) Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. Thromb Res 108:279–285CrossRefPubMedGoogle Scholar
  37. 37.
    Thomas IH, Zierler BK (2005) An integrative review of outcomes in patients with acute primary upper extremity deep venous thrombosis following no treatment or treatment with anticoagulation, thrombolysis, or surgical algorithms. Vasc Endovasc Surg 39:163–174CrossRefGoogle Scholar
  38. 38.
    Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, Morrow B, Clement AM, Wells PS (2007) A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 5:1650–1653CrossRefPubMedGoogle Scholar
  39. 39.
    Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson D (2005) Randomised placebo-controlled study of low-dose warfarin for the prevention of central venous catheter related thrombosis in patients with cancer. J Clin Oncol 23:4063–4069CrossRefPubMedGoogle Scholar
  40. 40.
    Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, Shepherd S, Stanley A, Sweeney A, Wilde J, Wheatley K, on behalf of the WARP Collaborative Group, UK (2009) Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 373:567–574CrossRefPubMedGoogle Scholar
  41. 41.
    Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Sorarù M, Mosca S (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomised study in cancer patients. J Clin Oncol 23:4057–4062CrossRefPubMedGoogle Scholar
  42. 42.
    Abdelkefi A, Ben Othman T, Kammoun L, Chelli M, Romdhane NB, Kriaa A, Ladeb S, Torjman L, Lakhal A, Achour W, Ben Hassen A, Hsaïri M, Ladeb F, Ben Abdeladhim A (2004) Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomised controlled trial. Thromb Haemost 92:654–661PubMedGoogle Scholar
  43. 43.
    Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD (2008) Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost 99:38–43PubMedGoogle Scholar
  44. 44.
    Cunningham MS, White B, Hollywood D, O’Donnell J (2006) Primary thromboprophylaxis for cancer patients with central venous catheters: a reappraisal of the evidence. Br J Cancer 94:189–194CrossRefPubMedGoogle Scholar
  45. 45.
    Kommareddy A, Zaroukian MH, Hassouna HI (2002) Upper extremity deep venous thrombosis. Semin Thromb Hemost 28:89–99CrossRefPubMedGoogle Scholar
  46. 46.
    Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJM (2008) Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 118:1366–1372CrossRefPubMedGoogle Scholar
  47. 47.
    Prandoni P, Bernardi E, Marchiori A et al (2004) The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 329:484–485CrossRefPubMedGoogle Scholar
  48. 48.
    Elman EE, Kahn SR (2006) The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults. A systematic review. Thromb Res 6:609–614CrossRefGoogle Scholar
  49. 49.
    Lechner D, Wiener C, Weltermann A, Eischer L, Eichinger S, Kyrle A (2008) Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 6:1269–1274CrossRefPubMedGoogle Scholar
  50. 50.
    Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS (2005) Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost 93:499–502PubMedGoogle Scholar

Copyright information

© SIMI 2009

Authors and Affiliations

  1. 1.Department of Cardiologic, Thoracic, and Vascular Sciences, 2nd Chair of Internal MedicineUniversity of Padua Medical SchoolPaduaItaly

Personalised recommendations